Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer

The antiplatelet effect of low-dose aspirin, via inhibition of cyclooxygenase-1, might contribute to its ability to reduce risk of colorectal cancer (CRC). Antiplatelet agents with a different mechanism, such as clopidogrel, might have the same effects. We aimed to quantify the effects of low-dose aspirin and clopidogrel on risk of CRC in a Mediterranean population.

Source: Clinical Gastroenterology and Hepatology - December 20, 2018 Category: Gastroenterology Authors: Antonio Rodr íguez-Miguel, Luis A. García-Rodríguez, Miguel Gil, Héctor Montoya, Sara Rodríguez-Martín, Francisco J. de Abajo Source Type: research